Europe · Exchanges & live quotes · Bourse Direct

Bayer publie des données de phase clinique favorables pour son Darolutamide

Published by Bourse Direct · France 1 h ago

Read the full article on Bourse Direct Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (news.google.com)

Also worth reading

Employees group warns of major Swiss job losses if UBS relocates

London Stock Exchange Group

LSEG significantly accelerates analysis of years of Tick History market data with NVIDIA cuDF

Marchés : un grand investisseur international achète des obligations françaises !

Investing.com Español

¿Puede la plata recuperarse tras su última caída? UBS analiza

Investir (cours en direct)

Kering voit la relance de Gucci contrariée par la baisse du trafic dans les magasins

Les actions à suivre jeudi: Covivio, FDJ United, ID Logistics, Imerys